Skip to search formSkip to main contentSkip to account menu

AF-102B

Known as: AF 102B, AF102B 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Cevimeline hydrochloridecevimeline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
AF150(S) and AF267B
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren’s Syndrome), AF150(S) and AF267B… 
2002
2002
AF150(S) and AF267B: M1 muscarinic agonists as innovative therapies for Alzheimer's disease.
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren's Syndrome), AF150(S) and AF267B… 
Highly Cited
1994
Highly Cited
1994
Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats
1992
1992
AF102B, a novel M1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of action
Highly Cited
1990
Highly Cited
1990
Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B
1990
1990
Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia
1989
1989
Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.
The effects of FKS-508 [AF102B; cis-2-methylspiro(1,3-oxathiolane-5,3')quinuclidine], a selective M1 muscarinic receptor agonist… 
Highly Cited
1988
Highly Cited
1988
Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.
1988
1988
Dual synaptic effects of activating M1-muscarinic receptors, in superior cervical ganglia of rabbits
1988
1988
Amelioration of experimental amnesia (passive avoidance failure) in rodents by the selective M1 agonist AF102B.
Effect of AF102B (cis-2-methylspiro-(1,3-oxathiolane-5,3')-quinuclidine) on experimental amnesia was examined using a passive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)